OnDemand
Clinical Trials Forum 2021
  • Detail & Program Access
  • Overview & Objectives
  • Credit Eligibility
  • Faculty
  • Agenda
  • Program Materials
  • Funding Support
CLICK HERE TO VIEW THE VIDEO

Program Access and Details:

Program Length:
90 minutes

Resources:
DOWNLOADABLE SLIDES. View the Program Materials tab for more information.

Credits:
This program is not accredited. Physicians may earn self-learning credits through active steps. View more information under the Credit Eligibility tab.

Target Audience:
Family physicians, cardiovascular specialists, allied health professionals

Clinical Trials Forum 2021

CLICK HERE TO VIEW THE VIDEO

Program Access and Details:

Program Length:
90 minutes

Resources:
DOWNLOADABLE SLIDES. View the Program Materials tab for more information.

Credits:
This program is not accredited. Physicians may earn self-learning credits through active steps. View more information under the Credit Eligibility tab.

Target Audience:
Family physicians, cardiovascular specialists, allied health professionals

Clinical Trials Forum 2021

This program reviews the most impactful trials of the year in cardiovascular medicine and diabetes.

The expert faculty will discuss the design, results, and clinical implications of the major cardiovascular trials presented in 2021 that inform patient care.

This program is NOT accredited.

Mainpro+ participants may earn certified credits by completing a Linking Learning Exercise.

Specialist participants may claim Section 2 credits (up to 2 credits per hour) following completion of a personal learning project (PLP) under Section 2: Self-Learning Activities within the MAINPORT ePortfolio.

Image
Deepak Bhatt
MD, MPH, FACC, FAHA, FSCAI, FESC

Boston, MA

Image
Milan Gupta
MD, FRCPC, FCCS, CPC(HC)

Brampton, ON

Image
Narendra Singh
MD, FRCPC, FCCS, FACC, FAHA

Atlanta, GA

Program Chapter
Presenter
Opening Comments
Milan Gupta
What Is The Current Role For Incretin Therapies In CV Risk Reduction And Obesity Management? (AMPLITUDE, SURPASS, STEP program)
Narendra Singh
What Are The Latest Treatment Options For Patients With Chronic Kidney Disease? (CREDENCE, DAPA-CKD, FIDELIO and FIGARO-DKD)
Milan Gupta
What Are The Latest Advances In Structural Heart Disease? (LAAOS III, AVATAR)
Narendra Singh
Is There A Role For SGLT2 Inhibitors In Heart Failure Regardless Of Ejection Fraction? (EMPEROR-Preserved, SOLOIST-WHF, CHIEF-HF, EMPULSE)
Milan Gupta

Program slides:

This program was developed by the Canadian Collaborative Research Network, a not-for-profit physician organization.  A PDF copy of the slides from this program are available for CCRN members from the CCRN website. Click the link below to be directed to the Resource Library.

Visit www.ccrnmd.com/resources to download the materials.

This program has been developed by the Canadian Collaborative Research Network, a not-for-profit physician organization, and was supported through an educational grant received from:

GOLD

 

 

SILVER